USTR issued 2012 Special 301 report
United States Trade Representative issued 301 report that reflects the Administration’s resolve to encourage and maintain effective IPR protection and enforcement worldwide. It identifies a wide range...
View ArticleUS Special 301 report 2013: India on priority watch list again
Excerpts from the report on India: India remains on the Priority Watch List in 2013. In 2012, India made limited progress in improving its weak IPR legal framework and enforcement system. Comments on...
View ArticlePhRMA press release on the Special 301 Report
Source: PhRMA May 1,2013 PHRMA STATEMENT ON 2013 SPECIAL 301 REPORT WASHINGTON, D.C. (May 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice President Jay Taylor...
View ArticleComments Posted for ‘Special 301′ Review of Foreign Nations’ Intellectual...
Source: Info Justice 11 Feb 2014 Last Friday, an interagency committee led by the U.S. Trade Representative received comments for the 2014 Special 301 Review. This annual review is a process in which...
View ArticleTrade team in US to explain India’s position
Source: Business Line 13 Feb 2014 Indian drugmakers and IT representatives will be in Washington tomorrow, making submissions before the US International Trade Commission to explain India’s trade...
View ArticleWatch happens next -Will the US back off in the face of India’s hardened...
The public hearing on Special 301 report for 2014 hearing took place yesterday in Washington DC. This report prepared annualy by USTR identifies countries that allegedly “deny adequate and effective”...
View ArticleStatement by South Centre in response to Special 301 review by USTR...
Source: South Centre 5 March 2014 Unilateral US actions targeting India’s Intellectual Property Laws undermines the Legitimacy of the WTO...
View ArticleUS experts, non-profits back India’s intellectual property laws, say any...
Source: Financial Times 24 March 2014 New Delhi : Even as Washington deliberates imposing trade sanctions on India, a move that could impact import of pharmaceutical, gems & jewellery and petroleum...
View ArticleThree major US firms back India’s drug patent regime
Source: Economic Times 1 May 2014 NEW DELHI: Three major US companies – Boeing, AbbottBSE 0.21 % and HoneywellBSE 1.19 % – have come in support of India’s IPR regime, which has come under attack by...
View ArticleUS maintains status quo on India’s patent regime
Source: Business Standard 1 May 2014 Special 301 Report expresses concern over weak IPR laws, to conduct reviews In its much-awaited Annual Special 301 Report, the US Trade Representative (USTR) on...
View ArticleUS places India on IPR Priority Watch List
Source: The Pioneer 1 May 2014 The US Wednesday put India and nine other countries on its Priority Watch List to highlight what it called “growing concerns with respect to the environment for...
View ArticleNo downgrade but India still on US priority watch list on intellectual...
Source: Live Mint 1 May 2014 US trade representative says it will try to resolve ongoing concerns through bilateral engagement The US trade representative did not designate any countries a ‘priority...
View ArticleSpecial 301 report: US holds its punches, sticks with earlier grading on India
Source: Business Line 1 May 2014 Mumbai, May 1: Despite the high-profile criticism on India’s trade practices in some quarters, the United States government has decided not to rock the boat, and has...
View ArticleIndia not in US list of patent rights offenders
Source: The Indian Express 1 May 2014 The US on Wednesday kept India out of Priority Foreign Country list, reserved for the worst offenders of intellectual property rights and said it will hold...
View ArticleIndian elections influenced US decision on Special 301 Review
Source: The Economic Times WASHINGTON: The desire of the Obama Administration to start its relationship with the new Indian government after the general elections on a positive note is believed to have...
View ArticlePhRMA Statement on 2014 Special 301 Report
Source: Market Watch 1 May 2014 WASHINGTON, Apr 30, 2014 (BUSINESS WIRE) — Pharmaceutical Research and...
View ArticleMSF response to USTR’s Special 301 Report
Source: MSF Access Campaign 4 May 2014 MSF responds to US Trade 301 Watch List BACKGROUND In the U.S. Trade Representative (USTR) 2014 “Special 301 Report” released today, India remains on the Priority...
View ArticleUS faces pressure to take India to WTO
Source: The Times of India 6 May 2014 NEW DELHI: The US government is coming under intense pressure from lawmakers to act against India at the World Trade Organization (WTO) for what they say are...
View ArticleIssues of concern around Commerce and Industry Minister’s Statement on IP Policy
Statement of Organisations and Individuals Tuesday, 23 September 2014 We, the undersigned organisations and individuals, understand that ahead of Prime Minister Narendra Modi’s scheduled visit to the...
View ArticleDIPP Statement on Bilateral Mechanism for Discussing IPR Issues with USA
Source: Press Information Bureau The US- India Joint Statement issued by the Prime Minister of India and the President of the United States of America after the bilateral summit had the following...
View Article